Real-world effectiveness of upadacitinib in moderate-to-severe atopic dermatitis (AD): Results from cross-sectional analyses of the CorEvitas AD Registry
BRITISH JOURNAL OF DERMATOLOGY（2024）
关键词
atopic dermatitis,moderate-to-severe,patient-reported outcomes,upadacitinib,CorEvitas AD registry (formerly Corrona AD registry)
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要